Can medical cannabis reduce pain from post-herpetic neuralgia?

PostedFebruary 17, 2026

UpdatedFebruary 17, 2026

ByMy Patient Advice

Author: Julia Sutton, MSc | Reviewed by: Dr. Clarissa Morton, PharmD

Yes, early research and patient experiences suggest that cannabis post-herpetic neuralgia pain relief may be possible, particularly for those who have not responded well to conventional treatments. Post-herpetic neuralgia is a long-lasting nerve pain condition that follows a shingles outbreak, often causing burning, stabbing, or electric shock-like sensations in the affected area.

As this type of nerve pain is often difficult to treat, many are turning to cannabis post-herpetic neuralgia pain relief as a potential therapeutic option, especially when standard medications such as gabapentin or amitriptyline fail to offer relief.

How Cannabis May Help with Shingles-Related Nerve Pain

Cannabis interacts with the endocannabinoid system, which regulates pain, inflammation, and nerve function. Here are the key ways cannabis may provide support.

Pain modulation via cannabinoid receptors

THC and CBD can influence CB1 and CB2 receptors in the nervous system, helping to dull the transmission of pain signals. This supports the use of medical cannabis for shingles nerve pain, particularly in persistent or severe cases.

Anti-inflammatory properties

Cannabis may reduce inflammation around damaged nerve tissues, which can help minimise sensitivity and ongoing pain. This contributes to broader neuralgia with cannabis treatment outcomes.

Sleep and anxiety support

Chronic nerve pain often causes sleep disturbances and anxiety. Cannabis can aid relaxation and improve rest, indirectly supporting pain management.

Complementary therapy

While not a cure, cannabis for post herpetic pain may serve as a useful adjunct to other medications, especially when combined with physiotherapy or topical agents.

In conclusion, cannabis post-herpetic neuralgia pain relief appears promising for patients seeking alternative or supplemental pain management. As with any treatment, use should be supervised by a medical professional experienced in cannabinoid therapy.

If you’re exploring cannabis treatment options for neuropathic pain, visit providers like LeafEase for personalised consultations and guidance tailored to your needs.

For a deeper dive into the science, diagnosis, and full treatment landscape, read our complete guide to Medical Cannabis and neuropathic pain

Julia Sutton, MSc

Author

Julia Sutton is a clinical psychologist with a Master’s in Clinical Psychology and experience providing psychological assessment and therapy to adolescents and adults. Skilled in CBT, client-centered therapy, and evidence-based interventions, she has worked with conditions including depression, anxiety, bipolar disorder, and conversion disorder. She also has experience in child psychology, conducting psycho-educational evaluations and developing tailored treatment plans to improve learning and well-being.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the author's privacy.

Dr. Clarissa Morton, PharmD

Reviewer

Dr. Clarissa Morton is a licensed pharmacist with a Doctor of Pharmacy degree and experience across hospital, community, and industrial pharmacy. She has worked in emergency, outpatient, and inpatient pharmacy settings, providing patient counseling, dispensing medications, and ensuring regulatory compliance. Alongside her pharmacy expertise, she has worked as a Support Plan & Risk Assessment (SPRA) officer and in medical coding, applying knowledge of medical terminology, EMIS, and SystmOne software to deliver accurate, compliant healthcare documentation. Her skills span medication safety, regulatory standards, healthcare data management, and statistical reporting.

All qualifications and professional experience stated above are authentic and verified by our editorial team. However, pseudonym and image likeness are used to protect the reviewers's privacy.